This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cytokinetics Inc (CYTK)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 65.08M 20.21M 20.16M 14.91M
Receivables 12.00K 46.65M 5.00K 4.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 113.11M 131.13M 79.34M 76.43M
Property, Plant & Equipment, Gross 22.59M 21.96M 22.21M 24.29M
Accumulated Depreciation & Depletion 20.84M 20.33M 20.99M 23.29M
Property, Plant & Equipment, Net 1.75M 1.64M 1.22M 997.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 379.00K 200.00K 2.63M 127.00K
Total Non-Current Assets 2.13M 1.84M 3.85M 1.12M
Liabilities & Shareholder Equity
Total Assets 115.24M 132.97M 83.19M 77.55M
Accounts Payable 2.24M 1.36M 3.71M 2.15M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 132.00K 52.00K 0.00 0.00
Total Current Liabilities 31.65M 23.86M 26.70M 7.11M
Long Term Debt 14.64M 0.00 0.00 0.00
Deferred Income Taxes 359.00K 491.00K 542.00K 361.00K
Other Non-Current Liabilities 0.00 16.56M 1.50M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 15.00M 17.05M 2.04M 361.00K
Total Liabilities 46.65M 40.90M 28.75M 7.47M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 68.59M 92.06M 54.44M 70.08M
Common Par 40.00K 39.00K 31.00K 143.00K
Additional Paid In Capital 603.14M 589.27M 537.00M 518.80M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -534.74M -497.24M -482.60M -448.88M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 149.00K -4.00K 7.00K 18.00K
Total Capitalization 83.23M 92.06M 54.44M 70.08M
Total Equity 68.59M 92.06M 54.44M 70.08M
Total Liabilities & Stock Equity 115.24M 132.97M 83.19M 77.55M
Total Common Shares Outstanding 39.58M 38.66M 30.68M 23.74M
Preferred Shares 0.00 4.00K 4.00K 23.03K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 38.81M 35.71M 27.27M 18.11M
Diluted Weighted Shares Outstanding 38.81M 35.71M 27.27M 18.11M
Number of Employees 100 92 85 70
Number of Part-Time Employees 0 0 0 0
CYTK News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

CYTK Cytokinetics Inc

Chart of CYTK

Analysts Ratings for CYTK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CYTK ANALYST REPORT

CYTK Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs